Skip to main content

Sucroferric Oxyhydroxide use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Sep 8, 2023.

Drugs containing Sucroferric Oxyhydroxide: Velphoro

Sucroferric Oxyhydroxide Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because sucroferric oxyhydroxide is not absorbed orally, it will not reach the bloodstream of the infant or cause any adverse effects in breastfed infants.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Sucroferric Oxyhydroxide

CAS Registry Number

8047-67-4

Drug Class

Breast Feeding

Lactation

Milk, Human

Ferric Compounds

Iron Compounds

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.